188 related articles for article (PubMed ID: 36221953)
1. TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.
Lam YK; Yu J; Huang H; Ding X; Wong AM; Leung HH; Chan AW; Ng KK; Xu M; Wang X; Wong N
Hepatology; 2023 Sep; 78(3):727-740. PubMed ID: 36221953
[TBL] [Abstract][Full Text] [Related]
2. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2020 May; ():. PubMed ID: 32428506
[TBL] [Abstract][Full Text] [Related]
4. TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.
Shen T; Li SF; Wang JL; Zhang T; Zhang S; Chen HT; Xiao QY; Ren WH; Liu C; Peng B; Ji XN; Yang Y; Lu PX; Chen TY; Yu L; Ji Y; Jiang DK
Liver Int; 2020 Nov; 40(11):2834-2847. PubMed ID: 32594568
[TBL] [Abstract][Full Text] [Related]
5. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.
Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; Caron de Fromentel C; Chemin IA; Hainaut PL
Carcinogenesis; 2010 Aug; 31(8):1475-82. PubMed ID: 20538734
[TBL] [Abstract][Full Text] [Related]
6. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
[TBL] [Abstract][Full Text] [Related]
8. It takes a team: a gain-of-function story of p53-R249S.
Wang H; Liao P; Zeng SX; Lu H
J Mol Cell Biol; 2019 Apr; 11(4):277-283. PubMed ID: 30608603
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
[TBL] [Abstract][Full Text] [Related]
10. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Woo HG; Wang XW; Budhu A; Kim YH; Kwon SM; Tang ZY; Sun Z; Harris CC; Thorgeirsson SS
Gastroenterology; 2011 Mar; 140(3):1063-70. PubMed ID: 21094160
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.
Han C; Yu T; Qin W; Liao X; Huang J; Liu Z; Yu L; Liu X; Chen Z; Yang C; Wang X; Mo S; Zhu G; Su H; Li J; Qin X; Gui Y; Mo Z; Li L; Peng T
J Gastrointest Oncol; 2020 Dec; 11(6):1333-1349. PubMed ID: 33457005
[TBL] [Abstract][Full Text] [Related]
13. Context-specific roles of diphthamide deficiency in hepatocellular carcinogenesis.
Tu WL; Chih YC; Shih YT; Yu YR; You LR; Chen CM
J Pathol; 2022 Oct; 258(2):149-163. PubMed ID: 35781884
[TBL] [Abstract][Full Text] [Related]
14. Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma.
Ortiz-Cuaran S; Cox D; Villar S; Friesen MD; Durand G; Chabrier A; Khuhaprema T; Sangrajrang S; Ognjanovic S; Groopman JD; Hainaut P; Le Calvez-Kelm F
Genes Chromosomes Cancer; 2013 Oct; 52(10):912-9. PubMed ID: 23836507
[TBL] [Abstract][Full Text] [Related]
15. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
Ortiz-Cuaran S; Villar S; Gouas D; Ferro G; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
Cancer Lett; 2013 Apr; 331(1):46-51. PubMed ID: 23200676
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
17. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
[TBL] [Abstract][Full Text] [Related]
18. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
19. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
[TBL] [Abstract][Full Text] [Related]
20. MiR-30e-3p Influences Tumor Phenotype through
Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
